Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
An anti-mesothelin antibody of human origin has been generated; it has the ability to efficiently recognize mesothelin on the surface of cells, and induce ADCC in mesothelin-positive cells. More
New SS1P constructs include Pseudomonas Exotoxin A fragments and mutants with reduced immunogenicity, resulting in immunotoxins with greater efficacy. More
New monoclonal antibodies against megakaryocyte potentiation factor More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jul 2011 - 220 pages - $500
Dec 2010 - 62 pages - $1,000
Jan 2011 - 50 pages - $500
Jul 2011 - 74 pages - $2,000
Nov 2010 - 1535 pages - $1,495
Nov 2011 - 48 pages - $5,700
Jul 2010 - 135 pages - $1,740
Oct 2011 - 63 pages - $500
Jul 2011 - 837 pages - $500
Jun 2011 - 187 pages - $3,835
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us